Krypton Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 1.00 M
as on 06-07-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 3.93%
(FY 2022)
- Ebitda 3.93%
(FY 2022)
- Net Worth -2.83%
(FY 2022)
- Total Assets 16.76%
(FY 2022)
About Krypton Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anand Agrawal, Magan Mehrotra, Indu Agrawal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100UP2019PTC116698
- Company No.
116698
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Moradabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Krypton Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Agrawal  | Director | 08-May-2019 | Current |
| Magan Mehrotra | Director | 08-May-2019 | Current |
| Indu Agrawal | Director | 08-May-2019 | Current |
| Raj Kapoor | Director | 08-May-2019 | Current |
Financial Performance of Krypton Life Sciences.
Krypton Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.93% increase in profit. The company's net worth dipped by a decrease of 2.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krypton Life Sciences?
Unlock access to Krypton Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Aanandlok Remedial Research Centre Private LimitedActive 16 years 6 months
Anand Agrawal is a mutual person
- Krypton Progressive Institutions Private LimitedActive 8 years 6 months
Indu Agrawal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Krypton Life Sciences?
Unlock and access historical data on people associated with Krypton Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krypton Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krypton Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
